ReviewAnnals of medicine and surgery (2012)2026
Trends in diabetes and stroke-related mortality in the United States, 1999-2024: a population-based analysis.
Review in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Trends and disparities in deaths involving atherosclerotic cardiovascular disease and stroke-related conditions among U.S. adults, 1999-2025.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Stroke remains a leading cause of cardiovascular mortality and disability in the United States, with diabetes serving as a major comorbidity that exacerbates outcomes and economic burden. Individuals affected by both diabetes and stroke experience heightened risks of death, disability, and healthcare utilization. This study examines national trends in diabetes and stroke-related mortality from 1999 to 2024, stratified by demographic and geographic factors. Methods: Mortality data were extracted from the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research Multiple Cause of Death database. Deaths were identified using International Classification of Diseases, 10th Revision codes for diabetes mellitus and stroke, defined as deaths in which both conditions were listed on the death certificate, either as underlying or contributing causes. Both crude and age-adjusted mortality rates (AAMRs) per 100 000 were calculated, standardized to the 2000 US population. Temporal patterns were assessed using Joinpoint regression to estimate annual percent change with 95% confidence intervals. Analyses were further stratified by age, sex, race, ethnicity, urbanization, and census region. Results: Between 1999 and 2024, 617 059 deaths were attributed to the combined burden of diabetes and stroke. National AAMR declined from 10.4 to 7.0 per 100 000, showing significant decreases until 2018, followed by an increase during 2018-2021 and subsequent decline through 2024. Mortality remained higher among men, non-Hispanic Black individuals, rural populations, and residents of Southern states. Conclusion: Although long-term mortality declined, recent reversals and enduring disparities emphasize the urgent need for integrated prevention and equitable public health strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.